PWP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.419400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.591000E-01
Normal-vs-Stage2
7.630600E-01
Normal-vs-Stage3
7.569200E-01
Normal-vs-Stage4
9.045400E-01
Stage1-vs-Stage2
3.912800E-01
Stage1-vs-Stage3
9.960600E-01
Stage1-vs-Stage4
2.350200E-01
Stage2-vs-Stage3
7.948400E-01
Stage2-vs-Stage4
8.255400E-01
Stage3-vs-Stage4
7.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.574600E-01
Normal-vs-AfricanAmerican
2.823200E-01
Normal-vs-Asian
7.046000E-01
Caucasian-vs-AfricanAmerican
1.121390E-03
Caucasian-vs-Asian
9.365400E-01
AfricanAmerican-vs-Asian
4.142200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.574800E-01
Normal-vs-Female
8.492200E-01
Male-vs-Female
3.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.248800E-01
Normal-vs-Age(41-60Yrs)
8.768400E-01
Normal-vs-Age(61-80Yrs)
6.564000E-01
Normal-vs-Age(81-100Yrs)
7.847400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.687000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.495200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.659000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.470770E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.545800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.763440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.655800E-01
Normal-vs-Daily Drinker
6.174800E-01
Normal-vs-Weekly Drinker
9.899600E-01
Normal-vs-Occasional Drinker
9.616200E-01
Normal-vs-Social Drinker
5.009000E-01
Non Drinker-vs-Daily Drinker
5.049800E-01
Non Drinker-vs-Weekly Drinker
5.769000E-01
Non Drinker-vs-Occasional Drinker
6.037000E-01
Non Drinker-vs-Social Drinker
6.124000E-01
Daily Drinker-vs-Weekly Drinker
3.441200E-01
Daily Drinker-vs-Occasional Drinker
3.204800E-01
Daily Drinker-vs-Social Drinker
8.407800E-01
Weekly Drinker-vs-Occasional Drinker
9.185200E-01
Weekly Drinker-vs-Social Drinker
3.417200E-01
Occasional Drinker-vs-Social Drinker
3.168800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.207400E-01
Normal-vs-Grade 2
6.959600E-01
Normal-vs-Grade 3
6.834600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.378820E-01
Grade 1-vs-Grade 3
1.132820E-01
Grade 1-vs-Grade 4
5.207400E-01
Grade 2-vs-Grade 3
8.010800E-01
Grade 2-vs-Grade 4
6.959600E-01
Grade 3-vs-Grade 4
6.834600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.511400E-01
Normal-vs-NonDiabetic
7.818800E-01
Diabetic-vs-NonDiabetic
2.667200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.881800E-01
Normal-vs-NoPancreatitis
6.566200E-01
Pancreatitis-vs-NoPancreatitis
5.904100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.453600E-01
Normal-vs-N1
7.405800E-01
N0-vs-N1
5.676000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.121600E-01
Normal-vs-TP53-NonMutant
6.147800E-01
TP53-Mutant-vs-TP53-NonMutant
3.842800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
